XML 64 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCKHOLDERS' EQUITY (Details Narrative 3) - USD ($)
3 Months Ended 9 Months Ended
Sep. 28, 2017
Sep. 25, 2017
Aug. 06, 2017
Aug. 01, 2017
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Share-based compensation expense         $ 2,109,218 $ 1,885,050 $ 5,981,343 $ 4,691,735  
Total unrecognized estimated compensation expense         $ 14,203,000   $ 14,203,000    
Recognized weighted-average period             2 years 2 months 12 days    
Underwriting Agreement [Member] | Goldman Sachs & Co. LLC, [Member]                  
Issue of common stock (in shares)       12,745,098          
Issue of common stock (in dollars per shares)       $ 5.10          
Common stock exercisable shares       1,911,764          
Stock exercisable period       30 days          
Net Proceeds       $ 69,908,000          
Underwriting Agreement [Member] | J.P. Morgan Securities LLC [Member]                  
Issue of common stock (in shares) 12,400,000 12,400,000              
Issue of common stock (in dollars per shares)   $ 5.55              
Net Proceeds   $ 68,573,000              
Knight License Agreement [Member] | Knight Therapeutics Inc. [Member]                  
Issue of common stock value     $ 20,000,000            
Stock Options [Member]                  
Options outstanding, ending         24,837,349   24,837,349   23,365,225
Weighted average grant date fair value per share of options granted             $ 3.27 $ 3.82  
Options outstanding         $ 4.15   4.15   $ 3.78
Stock Options [Member] | Minimum [Member]                  
Option exercise prices (in dollars per shares)         0.10   0.10    
Stock Options [Member] | Maximum [Member]                  
Option exercise prices (in dollars per shares)         $ 8.92   $ 8.92    
Cash-Settled Stock Appreciation Rights (SARs) [Member]                  
Options outstanding, ending         106,000   106,000    
Options outstanding         $ 1.36   $ 1.36    
2012 Stock Incentive Plan [Member]                  
Number of shares authorized for issuance         10,000,000   10,000,000    
Number of shares available for issuance         3,473,333   3,473,333    
2009 Long Term Incentive Compensation Plan [Member]                  
Number of shares authorized for issuance         25,000,000   25,000,000    
Number of shares available for issuance         900,037   900,037    
Warrants [Member]                  
Recognized weighted-average period             6 months    
Warrants [Member] | Individuals [Member]                  
Shares issued for exercise of warrants, net               $ 3,798,999  
Shares issued for exercise of warrants, net (in shares)               2,476,666